Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × tivozanib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 4 Prostatic Neoplasms 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Sarcoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Gallbladder Neoplasms 1 Disease Progression 1 Clear-cell metastatic renal cell carcinoma 1 Cholangiocarcinoma 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1

Interventions

pembrolizumab 5 Cetuximab 5 atezolizumab 3 spartalizumab 2 olaparib 2 fludarabine 2 Trastuzumab 2 Injections 2 Docetaxel 2 Cyclophosphamide 2 Bevacizumab 2 zolbetuximab 1 zimberelimab 1 zansecimab 1 tocilizumab 1 taxane 1 somatostatin receptor 2 1 ribociclib 1 pralsetinib 1 pertuzumab 1 pegylated granulocyte colony-stimulating factor 1 lenvatinib 1 ipatasertib 1 inavolisib 1 fludarabine phosphate 1 entrectinib 1 encorafenib 1 durvalumab 1 dapagliflozin 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡